SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura.
作者信息
Shah Hridaya, Kim Ann, Sukumar Senthil, Mazepa Marshall, Kohli Ruhail, Braunstein Evan M, Brodsky Robert A, Cataland Spero, Chaturvedi Shruti
机构信息
Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Medicine, Johns Hopkins University, Baltimore, MD.
出版信息
Blood. 2022 Apr 21;139(16):2570-2573. doi: 10.1182/blood.2022015545.
Abstract
摘要
相似文献
1
SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura.
Blood. 2022 Apr 21;139(16):2570-2573. doi: 10.1182/blood.2022015545.
2
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.
Haematologica. 2023 Nov 1;108(11):3152-3155. doi: 10.3324/haematol.2022.282478.
3
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
4
Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.
BMJ Case Rep. 2022 Jul 28;15(7):e247524. doi: 10.1136/bcr-2021-247524.
5
Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.
Thromb Haemost. 2023 Oct;123(10):945-954. doi: 10.1055/s-0043-1768921. Epub 2023 May 12.
6
Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination.
Blood. 2022 Apr 21;139(16):2565-2569. doi: 10.1182/blood.2021015149.
7
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
Thromb Res. 2022 Jun;214:115-121. doi: 10.1016/j.thromres.2022.04.020. Epub 2022 May 2.
8
Covid-19 vaccination in patients with immune-mediated thrombotic thrombocytopenic purpura: a single-referral center experience.
Haematologica. 2023 Jul 1;108(7):1957-1959. doi: 10.3324/haematol.2022.282311.
9
Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e429-e431. doi: 10.1111/jdv.18014. Epub 2022 Feb 23.
10
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.
Int J Hematol. 2021 Nov;114(5):626-629. doi: 10.1007/s12185-021-03190-y. Epub 2021 Jul 15.
引用本文的文献
1
Immune Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, Therapy and Open Issues.
Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024060. doi: 10.4084/MJHID.2024.060. eCollection 2024.
2
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.
Cardiovasc Diabetol. 2024 Feb 20;23(1):75. doi: 10.1186/s12933-023-02097-8.
3
Thrombocytopenic thrombotic purpura related to COVID-19 vaccine: apropos of 4 cases.
Hematol Transfus Cell Ther. 2024 Oct-Dec;46(4):511-515. doi: 10.1016/j.htct.2023.11.008. Epub 2023 Dec 30.
4
Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection.
Viruses. 2023 Apr 25;15(5):1045. doi: 10.3390/v15051045.
5
Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review.
Diagnostics (Basel). 2023 Mar 24;13(7):1228. doi: 10.3390/diagnostics13071228.
6
Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies.
Vaccines (Basel). 2023 Mar 15;11(3):662. doi: 10.3390/vaccines11030662.
7
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients.
Haematologica. 2023 Nov 1;108(11):3152-3155. doi: 10.3324/haematol.2022.282478.
8
Hematological Questions in Personalized Management of COVID-19 Vaccination.
J Pers Med. 2023 Jan 30;13(2):259. doi: 10.3390/jpm13020259.
9
[Chinese consensus on severe acute respiratory syndrome coronavirus-2 vaccination in adult patients with hematological diseases (2023)].
Zhonghua Xue Ye Xue Za Zhi. 2023 Jan 14;44(1):19-25. doi: 10.3760/cma.j.issn.0253-2727.2023.01.004.
10
Covid-19 vaccination in patients with immune-mediated thrombotic thrombocytopenic purpura: a single-referral center experience.
Haematologica. 2023 Jul 1;108(7):1957-1959. doi: 10.3324/haematol.2022.282311.
本文引用的文献
1
Acquired thrombotic thrombocytopenic purpura following Pfizer COVID-19 vaccination.
EJHaem. 2021 Nov 16;3(1):207-210. doi: 10.1002/jha2.342. eCollection 2022 Feb.
2
Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine.
BMJ Case Rep. 2021 Oct 8;14(10):e246049. doi: 10.1136/bcr-2021-246049.
3
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
Blood. 2022 Mar 10;139(10):1564-1574. doi: 10.1182/blood.2021013411.
4
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
Blood. 2021 Dec 2;138(22):2256-2268. doi: 10.1182/blood.2021013231.
5
Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19.
Case Rep Hematol. 2021 Sep 13;2021:4130138. doi: 10.1155/2021/4130138. eCollection 2021.
6
Vaccinations and Autoimmune Diseases.
Vaccines (Basel). 2021 Jul 22;9(8):815. doi: 10.3390/vaccines9080815.
7
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.
Ann Hematol. 2022 Mar;101(3):717-719. doi: 10.1007/s00277-021-04584-y. Epub 2021 Jul 26.
8
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
Nat Med. 2021 Jul;27(7):1290-1297. doi: 10.1038/s41591-021-01408-4. Epub 2021 Jun 9.
9
First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.
J Thromb Haemost. 2021 Aug;19(8):2014-2018. doi: 10.1111/jth.15418. Epub 2021 Jul 5.
10
Exacerbation of immune thrombocytopenia following COVID-19 vaccination.
Br J Haematol. 2021 Nov;195(3):365-370. doi: 10.1111/bjh.17645. Epub 2021 Jun 24.
Zotero 插件